Amylyx Pharmaceuticals, Inc. Quarterly General and Administrative Expense in USD from Q1 2021 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Amylyx Pharmaceuticals, Inc. quarterly General and Administrative Expense history and growth rate from Q1 2021 to Q2 2022.
  • Amylyx Pharmaceuticals, Inc. General and Administrative Expense for the quarter ending June 30, 2022 was $30M, a 292% increase year-over-year.
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 $30M +$22.3M +292% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $26.4M +$20.3M +339% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q2 2021 $7.66M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $6M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.